2021
DOI: 10.1186/s12872-021-02225-w
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: a study of the National Health and Nutrition Examination Survey database

Abstract: Background Cardiovascular disease (CVD) is a common comorbidity associated with chronic obstructive pulmonary disease (COPD), but few studies have been conducted to identify CVD risk in COPD patients. This study was to develop a predictive model of CVD in COPD patients based on the National Health and Nutrition Examination Survey (NHANES) database. Methods A total of 3,226 COPD patients were retrieved from NHANES 2007–2012, dividing into the traini… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
4

Year Published

2022
2022
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 28 publications
0
12
0
4
Order By: Relevance
“…While the C-index of our model for predicting CVD amounted to 0.747, the parameters included (gender, age, peripheral blood neutrophil, RDW, LDH, HbA1c) were easily obtained and the model was presented as a nomogram. Compared with the prediction model developed by Shi et al [ 42 ], the parameters we included in the model were more simplified, and the nomogram was presented in a more intuitive form, which can effectively help clinicians and patients to early identify COPD coexisting CVD. Yukiyo Sakamoto et al developed a nomogram to predict COPD in-hospital mortality based on variables including age, gender, BMI, disturbance of consciousness, severe dyspnea, history of mechanical ventilation, pneumonia, and comorbid asthma on admission, with a C-index of 0.775 [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While the C-index of our model for predicting CVD amounted to 0.747, the parameters included (gender, age, peripheral blood neutrophil, RDW, LDH, HbA1c) were easily obtained and the model was presented as a nomogram. Compared with the prediction model developed by Shi et al [ 42 ], the parameters we included in the model were more simplified, and the nomogram was presented in a more intuitive form, which can effectively help clinicians and patients to early identify COPD coexisting CVD. Yukiyo Sakamoto et al developed a nomogram to predict COPD in-hospital mortality based on variables including age, gender, BMI, disturbance of consciousness, severe dyspnea, history of mechanical ventilation, pneumonia, and comorbid asthma on admission, with a C-index of 0.775 [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Second, due to the lack of spirometry data in the NHANES database 2005–2006, the selection of our included study subjects relied on questionnaire data rather than GOLD diagnostic criteria for hospitalized COPD, which may be biased to some extent. However, in a previous study based on the NHANES database 2007–2012 comparing AUC between COPD determined by spirometry data and questionnaire data, there was little difference in AUC which demonstrated a difference between COPD patients identified by the two modalities was small [ 42 ]. Third, since there were no data on lung function, we could not assess the relationship between COPD severity with CVD and COPD mortality, and the established nomogram did not include the COPD stage.…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis of RA was based on the self-reported information: “Has a doctor or other health professional ever told you that you had RA?”. The individuals would be diagnosed as having RA if the question were answered as “yes” [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…COPD is the fourth leading cause of death in the US [ 2 ]. Cholesterol levels are an important prognostic marker of cardiovascular risk in patients with COPD [ 3 ]. Exposure to cigarette smoke is the primary environmental factor associated with the development of COPD.…”
Section: Introduction To Hypercholesterolemia In Copdmentioning
confidence: 99%